Stock vs Stock Comparison

Elanco Animal Health Incorporated vs Abbott Laboratories

ABT wins the Tale of the Tape 7–1.

ELAN
ABT$86.99

🏆 Tale of the Tape

17
ELANABT
-4.9%Profitability (Net Margin)14.7%
Valuation (P/E)24.0x
-0.0%Efficiency (ROIC)10.1%
5/9Health (Piotroski F)5/9
Safety (Altman Z)4.9
6.2%Growth (Rev YoY)5.7%
Risk (Sharpe 1Y)-1.05
1.04xBalance Sheet (D/E)0.64x
FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricELANABT
Market Cap$149.1B
P/E Ratio24.0x
Forward P/E14.1x
P/B2.86x
Dividend Yield2.94%
Beta0.65

Quantitative Metrics

MetricELANABT
DCF Fair Value$13.36$57.20
DCF Upside-43.2%
Piotroski F5/95/9
Altman Z4.87
Beneish M-2.70-2.53
FCF Yield4.21%
Net Debt/EBITDA5.0x0.1x
ROIC-0.0%10.1%
WACC9.4%
ROIC – WACC0.7pp
Gross Margin55.0%56.4%
Net Margin-4.9%14.7%
Rev Growth YoY6.2%5.7%
Sharpe (1Y)-1.05
Max Drawdown 3Y
FCF Payout Ratio56%

ELAN Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

ELAN found in:

XPH1.66%
MDYG0.60%
SPMD0.31%
MDY0.31%
VFMO0.26%
VBR0.25%
VHT0.18%
VB0.14%
VXF0.14%
ONEO0.11%
VONV0.03%
ESGV0.02%
SPTM0.02%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ELAN vs ABT: Head-to-Head Analysis

Elanco Animal Health Incorporated (ELAN) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABT leads 7–1 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ELAN generates a return on invested capital (ROIC) of -0.0% compared to ABT's 10.1%. This suggests ABT is more effective at deploying capital to generate shareholder returns.

ELAN appears in 13 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ELAN or ABT?

Our quantitative analysis compares ELAN and ABT across nine fundamental dimensions. ABT wins the Tale of the Tape 7–1. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ELAN and ABT correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.